Santori & Peters Inc’s Biogen BIIB Stock Holding History

Santori & Peters Inc’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27	Closed	-$8K	–	111
2017 Q4	$8K	Buy	+27	New	+$8.66K	0.01%	338

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Santori & Peters Inc's BIIB Position: Q1 2018 in Review

Santori & Peters Inc sold out of Biogen (BIIB) in Q1 2018, closing a stake of 27 shares — an estimated $8K sold.

Santori & Peters Inc first reported a position in BIIB in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 1,101 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

Santori & Peters Inc reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 27 Biogen shares in Q1 2018, an estimated $8K.
Santori & Peters Inc first reported a position in Biogen in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Biogen position peaked at $8K in Q4 2017.
1,101 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.